Sustained attention and vigilance deficits associated with HIV and a history of methamphetamine dependence.

ABSTRACT:

Background

Human immunodeficiency virus (HIV)-associated neurocognitive disorders persist in the era of antiretroviral therapy. One factor that is elevated among persons with HIV (PWH) and independently associated with neurocognitive impairment is methamphetamine dependence (METH). Such dependence may further increase cognitive impairment among PWH, by delaying HIV diagnosis (and thus, antiretroviral therapy initiation), which has been posited to account for persistent cognitive impairment among PWH, despite subsequent treatment-related viral load suppression (VLS; <50 copies of the virus per milliliter in plasma or cerebrospinal fluid). This study examined the main and interactive (additive versus synergistic) effects of HIV and history of METH on the sustained attention and vigil

SUBMITTER: Pocuca N 

PROVIDER: S-EPMC7811354 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature